Literature DB >> 9267880

Cryptococcal meningitis following a thrombotic microangiopathy in an unrelated donor bone marrow transplant recipient.

R Miniero1, F Nesi, S Vai, G De Intinis, F Papalia, R Targhetta, A Busca, E Vassallo, M Giacchino.   

Abstract

In patients undergoing bone marrow transplantation cryptococcosis is rarely encountered. We report a fatal case of Cryptococcus meningitis in a 12-year-old girl with acute lymphoblastic leukemia (ALL) in second remission who had a transplant from a human leukocyte antigen (HLA)-identical unrelated bone marrow donor. The conditioning regimen was thiotepa, cyclophosphamide, and total body irradiation (TBI); graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporin A, methotrexate, and antilymphocyte globulin (ALG). The patient experienced stage III GVHD responsive to high-dose corticosteroids. On day +54 a thrombotic microangiopathy occurred. On day +64 neurological status worsened; a brain computed tomographic (CT) scan showed hyperdense lesions suggesting fungal infection. Detection of cryptococcal antigen by latex agglutination was positive but India ink stain and culture were negative. Despite treatment with amphotericin B, 5-flucytosine, and granulocyte-macrophage colony-stimulating factor, the patient died 13 days after the diagnosis.

Entities:  

Mesh:

Year:  1997        PMID: 9267880     DOI: 10.3109/08880019709028778

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection.

Authors:  Lori M Neal; Yafeng Qiu; Jooho Chung; Enze Xing; Woosung Cho; Antoni N Malachowski; Ashley R Sandy-Sloat; John J Osterholzer; Ivan Maillard; Michal A Olszewski
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

2.  Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?

Authors:  Paul Coppo; Christophe Adrie; Elie Azoulay; Ghislaine Leleu; Eric Oksenhendler; Lionel Galicier; Jean Roger Le Gall; Annette Bussel; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-02-21       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.